✓ Credit card payment restored — secure checkout via Privacy Shield

Ropark

✅ Manages Parkinson’s symptoms
✅ Reduces tremors
✅ Improves motor function
✅ Enhances quality of life
✅ Minimizes muscle stiffness

Ropark contains Ropinirole.

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per tablet
Select a strength above to see pack pricing.
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer

Ropark is an oral ropinirole (0.25 / 0.5 / 1 / 2 mg) tablet — a non-ergot dopamine agonist used to treat Parkinson disease and moderate-to-severe restless legs syndrome (RLS). It directly stimulates dopamine D2/D3 receptors in the brain, partially substituting for the dopamine that is no longer being made. Compared with pramipexole, ropinirole has higher CYP1A2 dependence (avoid with ciprofloxacin and fluvoxamine; smoking lowers levels). Compared with bromocriptine, it does not cause cardiac valve fibrosis. Critical safety signals: impulse-control disorders (gambling, hypersexuality, binge eating, compulsive shopping), sudden-onset sleep (sleep attacks while driving), and orthostatic hypotension. Dose must be titrated up slowly and tapered down slowly — never stopped abruptly.

What you get with MedsBase: WHO-GMP certified manufacturer · Discreet packaging · Worldwide shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What Is Ropark?

Ropark is an oral tablet containing ropinirole 0.25 / 0.5 / 1 / 2 mg. ropinirole is a non-ergot dopamine D2/D3 receptor agonist, originally introduced as Requip. Ropark is manufactured by a WHO-GMP certified facility and is bioequivalent to the originator brand at the same strength.

Ropinirole is one of the two most widely used non-ergot dopamine agonists (the other is pramipexole). It is suitable as monotherapy in early Parkinson disease — particularly in younger patients where delaying levodopa is desirable to delay levodopa-induced dyskinesia — and as adjunct in advanced disease. It also has a separate licence for moderate-to-severe restless legs syndrome (RLS).

How Does Ropark (ropinirole) Work?

Ropinirole directly stimulates dopamine D2 and D3 receptors (with the highest selectivity for D3) in the striatum and limbic system, partially substituting for missing dopamine in Parkinson disease. The high D3 selectivity is also responsible for the strong effect on restless legs syndrome. It does not affect serotonin 5-HT2B receptors, so unlike ergot agonists it does not cause cardiac valve fibrosis.

Who Is Ropark For?

Ropark is appropriate for adults with Parkinson disease (monotherapy in early disease, adjunct to levodopa in advanced disease) and for moderate-to-severe restless legs syndrome unresponsive to non-pharmacological measures and iron repletion. Younger Parkinson patients (under 65) often benefit most from starting with a dopamine agonist before levodopa, to delay onset of levodopa-induced dyskinesia.

Dosing and Titration

Dopamine agonist therapy must be titrated upwards over weeks to avoid intolerable nausea, postural hypotension and somnolence. The dose schedule below is a typical starting framework — your neurologist will tailor it to your response.

WeekDose for Parkinson diseaseDose for RLS
10.25 mg three times daily (0.75 mg/day)0.25 mg once at bedtime
20.5 mg three times daily (1.5 mg/day)0.5 mg once at bedtime
30.75 mg three times daily (2.25 mg/day)1 mg once at bedtime
41 mg three times daily (3 mg/day)2 mg once at bedtime
Maintenance3–9 mg/day in 3 divided doses (max 24 mg/day)2–4 mg at bedtime; max 4 mg/day for RLS

Ropinirole is also available in a once-daily prolonged-release (XL/Modutab) formulation for Parkinson disease, allowing single-dose administration of up to 24 mg/day. This Ropark presentation is the immediate-release tablet, taken three times daily for Parkinson disease or once at bedtime for restless legs.

⚠ Impulse-control disorders — the warning every patient (and partner) needs to hear Up to 14–17% of patients on dopamine agonists develop one or more impulse-control disorders: pathological gambling, compulsive shopping, hypersexuality, binge eating, or punding (repetitive purposeless behaviour). The risk is dose-dependent and is highest with non-ergot agonists. Patients are often unaware of the change — partners and family members may notice it first. If you or someone close to you observes any new compulsive behaviour, contact your neurologist promptly. Dose reduction or discontinuation usually reverses the behaviour within weeks.
⚠ Sudden-onset sleep (“sleep attacks”) All non-ergot dopamine agonists can cause sudden, irresistible episodes of sleep without warning — including while driving, eating, or in conversation. This is more common in the first months of treatment, at higher doses, and when combined with levodopa. Until you have been on a stable dose for at least 2 weeks and know how you respond, do not drive, operate machinery, or engage in activities where falling asleep would be dangerous.

Common Side Effects

Common (>10%): nausea, dizziness, somnolence, postural hypotension, peripheral oedema (ankle swelling), constipation, hallucinations (visual more than auditory), dyskinesia (when combined with levodopa).

Less common but serious: sudden-onset sleep, impulse-control disorders, livedo reticularis (mottled skin pattern), vivid dreams, leg oedema, syncope, dyskinesia, hallucinations, paranoia.

Rare: dopamine agonist withdrawal syndrome (DAWS) on rapid taper — depression, anxiety, panic, fatigue, drug craving, autonomic instability. This is the reason agonists must be tapered slowly.

Drug Interactions

  • Dopamine antagonists — metoclopramide, prochlorperazine, haloperidol, risperidone, olanzapine: pharmacological antagonism, may worsen Parkinson symptoms. Use domperidone or ondansetron for nausea instead.
  • CNS depressants — alcohol, benzodiazepines, opioids, sedating antihistamines: increased somnolence and sleep-attack risk.
  • Antihypertensives — additive postural hypotension. Stand up slowly. Monitor blood pressure during titration.
  • Levodopa — intentional combination, but may unmask dyskinesia. Lower the levodopa dose if dyskinesia emerges.
  • CYP1A2 inhibitors — ciprofloxacin and fluvoxamine markedly raise ropinirole levels — reduce dose. Smoking induces CYP1A2 and lowers levels; if you stop smoking, levels rise and dose may need reduction.

Frequently Asked Questions

Can I use Ropark as my only Parkinson medication?

Yes — especially in early Parkinson disease. Many neurologists start patients under 65–70 on a dopamine agonist alone, adding levodopa later when symptoms outgrow agonist therapy. This strategy delays levodopa-induced dyskinesia by years.

Why does the dose go up so slowly?

Dopamine receptors take days to weeks to adapt. Starting at full dose causes severe nausea, vomiting, dizziness and postural drops. Slow titration lets the brain and gut adjust. Skipping the titration schedule almost always results in stopping the drug because side effects feel intolerable.

Can I stop Ropark abruptly if I dislike it?

No. Sudden withdrawal causes dopamine agonist withdrawal syndrome: depression, anxiety, panic, drug craving and autonomic instability. Even short courses should be tapered over 7–14 days, and longer courses over weeks. Always do this with your neurologist.

What about gambling and other compulsive behaviours?

Approximately 1 in 6 patients on a dopamine agonist develops a new compulsive behaviour — gambling, online shopping, hypersexuality, binge eating. The patient often does not recognise it. Tell a partner or family member to watch for changes. If they appear, contact your neurologist promptly. The behaviour usually reverses with dose reduction.

Is Ropark safe to use long-term?

Yes, with monitoring. Long-term concerns are impulse-control disorders, peripheral oedema, daytime somnolence, and (rarely) hallucinations or psychosis — all manageable with dose adjustment. Unlike ergot agonists (e.g. bromocriptine, pergolide, cabergoline), non-ergot agonists do not cause cardiac valve fibrosis.

Will Ropark cause restless legs syndrome to come back?

Ropark is also licensed for restless legs syndrome at lower doses (0.25–4 mg at bedtime). Long-term use of dopamine agonists for RLS can cause augmentation — symptoms come on earlier in the day, become more intense, and spread to other body parts. If augmentation occurs, switch off the agonist (under specialist guidance) to a non-dopaminergic option such as gabapentin enacarbil or pregabalin.

Can I drink alcohol on Ropark?

Avoid heavy or regular drinking. Alcohol increases somnolence, sleep-attack risk, postural hypotension and the chance of unmasking impulse-control behaviour. An occasional drink with food is usually acceptable; ask your neurologist for individualised advice.

Can I drive while taking Ropark?

Not until you have been on a stable dose for at least 2 weeks and have not experienced any sleep attacks or excessive daytime sleepiness. Even then, if you ever fall asleep without warning, stop driving and tell your neurologist.

What if I miss a dose?

Take it as soon as you remember unless it is close to the next scheduled dose. Do not double up. If you miss several doses in a row, contact your neurologist — you may need to re-titrate from a lower dose to avoid first-dose nausea.

Can Ropark cause swelling of the legs?

Yes. Peripheral oedema (ankle swelling) affects 5–15% of users and is more common in older patients and at higher doses. It is dose-related and usually improves on dose reduction. Diuretics are not very effective; the better fix is reducing or rotating the agonist.

How does MedsBase ship Ropark?

Worldwide shipping in discreet packaging from a WHO-GMP certified manufacturer. Tablets are shipped in original sealed blister packs. Track your order from your MedsBase account.

Storage

Store at room temperature (15–30°C / 59–86°F), protected from heat, moisture and direct light. Keep in the original container with the lid tightly closed. Keep out of reach of children. Do not use beyond the expiry date printed on the packaging.

Medical Disclaimer

This information is provided for educational purposes only and is not a substitute for the advice of a qualified clinician. Parkinson disease and parkinsonian syndromes require individualised neurology care. Discuss all medications, supplements and pre-existing conditions with your doctor before starting, changing or stopping treatment. Do not abruptly discontinue dopaminergic therapy — sudden withdrawal can precipitate a neuroleptic malignant-like syndrome.

Related Alternatives

Other products in Chronic Conditions that customers also view:

More options in Parkinson's Disease Treatment

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

0.25 mg, 0.5 mg, 1 mg, 2 mg

Quantity

30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s

Reviews

There are no reviews yet

Add a review
Ropark Ropark
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Q & A

Ask a question
Ropark Ropark
Your question
* Question is required
Name
* Name is required
There are no questions yet